DRMADermata Therapeutics, Inc.

Nasdaq dermatarx.com


$ 3.57 $ -0.34 (-9.08 %)    

Tuesday, 21-May-2024 12:20:23 EDT
QQQ $ 454.82 $ -0.70 (-0.15 %)
DIA $ 398.57 $ -1.86 (-0.47 %)
SPY $ 530.36 $ -1.18 (-0.22 %)
TLT $ 91.26 $ 0.35 (0.38 %)
GLD $ 225.37 $ -3.02 (-1.35 %)
$ 3.4185
$ 3.81
$ 0.00 x 0
$ 0.00 x 0
$ 3.57 - $ 4.60
$ 3.37 - $ 38.55
228,420
na
1.52M
$ -17.39
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
2 03-21-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 02-21-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-15-2022 06-30-2022 10-Q
9 05-16-2022 03-31-2022 10-Q
10 03-28-2022 12-31-2021 10-K
11 11-15-2021 09-30-2021 10-Q
12 09-27-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata," or the "Company"), a late-stage biotechnolog...

 dermata-therapeutics-q1-2024-gaap-eps-047-misses-036-estimate

Dermata Therapeutics (NASDAQ:DRMA) reported quarterly losses of $(0.47) per share which missed the analyst consensus estimate o...

 dermata-therapeutics-fy23-eps-267-vs-1392-yoy

Full Year 2023 Financial ResultsAs of December 31, 2023, the Company had $7.4 million in cash and cash equivalents, compared to...

 why-applied-therapeutics-shares-are-trading-lower-by-over-35-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of Applied Therapeutics, Inc.

 dow-turns-lower-ism-services-pmi-falls-in-december

U.S. stocks traded mixed midway through trading, with the Dow Jones index falling around 70 points on Friday. The Dow traded d...

 why-is-aesthetic-skin-conditions-focused-dermata-therapeutics-stock-trading-higher-today

Dermata Therapeutics Inc (NASDAQ: DRMA) stock was trading higher Friday after the company announced the issuance of a new paten...

 why-dermata-therapeutics-shares-are-trading-higher-by-over-57-here-are-20-stocks-moving-premarket

Shares of Dermata Therapeutics, Inc. (NASDAQ: DRMA) rose sharply in pre-market trading after the company announced the issuan...

 dermata-enrolls-first-patient-in-pivotal-dmt310-phase-3-star-1-clinical-trial-for-acne-about-550-patients-will-be-treated-once-weekly-for-12-weeks

- About 550 patients will be treated once weekly for 12 weeks -- STAR-1 topline results expected in first quarter of 2025 -- Ac...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION